卖什么
面向患者的AI智能体。
商业模式拆解
买家：谁掌握预算？
未核实Health system, payor and pharma/device executives (operations, patient engagement, access) who book a meeting.
触发点：什么让他们现在购买？
Devices left unused, RPM non-transmission, churn and lost complaints; scarcity of clinical staff.
工作流：什么输入变成什么输出？
AI agent makes activation and onboarding calls, re-engages non-transmitting RPM patients, helps with cost/access, triages troubleshooting, captures structured complaints and escalates to clinicians.
经济账：省了什么，怎么收费？
ROI claim: protects RPM/therapy reimbursement and reduces churn; cites about 47% connect rate on hard-to-reach populations (Jul 2026).
渠道：怎么接触到客户？
Demo-led ("Book A Meeting"); no self-serve pricing shown.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2025-11-03 | C 轮 | $126M | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-13.